Finding the Truth,
Educated T-cells work well in blood cancers. NVS and U PENN have a colaboration working on similar effect. The ultimate outcome of this news, in my opinion, might be a combination of DC and activated/engineered T-cells to keep the immune system in check and provide even longer term immune memory with memory B-cells involved. The trial you referrence and others have led to premature deaths from immune response. For now, educated DC therapy offers the safest way to regulate immune responses. Dr. Linda Liau has already hinted at this type of combination potential with the UCLA T-cell clinical trial for GBM they are looking at.
Remember when I wrote that the price of NWBO had hit bottom in anticipation of a new news cycle? Today marks the beginning of that cycle.
News 
Market Data 
Discover 
